Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing eravacycline to ertapenem for complicated urinary tract infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• ERTAPENEM (ertapenem)
• Eravacycline (eravacycline)

Snippet

Sponsor: Tetraphase Pharmaceuticals, Inc | Conditions: Complicated Urinary Tract Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-10-02